Ibex™ Design is our offering for your preclinical and IND needs through to clinical phase I. It includes a pioneering fixed price gene-to-vial package, with delivery of drug product within 12 months and at least 1 kg drug substance. To further increase predictability for you, we offer a manufacturing slot reserved for your clinical resupply. Benefit from our proven GS Gene Expression System® bioprocess platform and a holistic development strategy with the endpoint in mind.
IbexTM Solutions in the news